Skopos Labs, Inc. Organogenesis Holdings Inc. Transaction History
Skopos Labs, Inc.
- $813 Million
- Q3 2025
A detailed history of Skopos Labs, Inc. transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Skopos Labs, Inc. holds 66,484 shares of ORGO stock, worth $301,172. This represents 0.04% of its overall portfolio holdings.
Number of Shares
66,484
Previous 40,087
65.85%
Holding current value
$301,172
Previous $181,000
66.3%
% of portfolio
0.04%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding ORGO
# of Institutions
125Shares Held
69.4MCall Options Held
15.1KPut Options Held
25-
Soleus Capital Management, L.P. Greenwich, CT12.1MShares$55 Million3.34% of portfolio
-
Morgan Stanley New York, NY11.8MShares$53.4 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN7.5MShares$34 Million4.08% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$23 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$22.8 Million0.0% of portfolio
About Organogenesis Holdings Inc.
- Ticker ORGO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 130,888,000
- Market Cap $593M
- Description
- Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...